DERMIRA ($DERM) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$0.16 per share, missing estimates of -$0.11 by $0.05. The company also reported revenue of $15,010,000, missing estimates of $15,231,660 by $-221,660.
You can see Quiver Quantitative's $DERM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DERMIRA Insider Trading Activity
DERMIRA insiders have traded $DERM stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $DERM stock by insiders over the last 6 months:
- CLAUDE MARAOUI (President & CEO) has made 0 purchases and 7 sales selling 165,117 shares for an estimated $844,125.
- JOSEPH BENESCH (CFO) has made 0 purchases and 2 sales selling 3,774 shares for an estimated $23,561.
- RAMSEY ALLOUSH (COO) sold 2,857 shares for an estimated $19,541
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DERMIRA Hedge Fund Activity
We have seen 31 institutional investors add shares of DERMIRA stock to their portfolio, and 17 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 930,603 shares (+inf%) to their portfolio in Q1 2025, for an estimated $5,490,557
- BLACKROCK, INC. added 491,108 shares (+922.5%) to their portfolio in Q2 2025, for an estimated $3,526,155
- CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. removed 338,050 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,427,199
- VANGUARD GROUP INC added 192,727 shares (+51.8%) to their portfolio in Q2 2025, for an estimated $1,383,779
- GEODE CAPITAL MANAGEMENT, LLC added 148,612 shares (+130.7%) to their portfolio in Q2 2025, for an estimated $1,067,034
- TANG CAPITAL MANAGEMENT LLC added 129,027 shares (+7.5%) to their portfolio in Q1 2025, for an estimated $761,259
- INFORMED MOMENTUM CO LLC added 95,067 shares (+inf%) to their portfolio in Q2 2025, for an estimated $682,581
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DERMIRA Analyst Ratings
Wall Street analysts have issued reports on $DERM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 07/30/2025
To track analyst ratings and price targets for DERMIRA, check out Quiver Quantitative's $DERM forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
